Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mathias Fink

2PUBLICATIONS

2CO-AUTHORS

Fermentation

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Feb 13, 2021

Integrated process development: The key to improve Fab production in E. coli.

Mathias Fink, Clemens Schimek, Monika Cserjan-Puschmann

|Jun 25, 2019

Microbioreactor Cultivations of Fab-Producing Escherichia coli Reveal Genome-Integrated Systems as Suitable for Prospective Studies on Direct Fab Expression Effects.

Mathias Fink, Sophie Vazulka, Esther Egger

Pageof 1

Frequent Collaborators

1 joint publications

Clemens Schimek

1 joint publications

Monika Cserjan-Puschmann

Frequent Collaborators

1 joint publications

Clemens Schimek

1 joint publications

Monika Cserjan-Puschmann

Top Related Videos

<em>Escherichia coli</em>-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology

<em>Escherichia coli</em>-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology

Published on : Feb 25, 2019

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

See more related videos

Top Related Videos

<em>Escherichia coli</em>-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology

<em>Escherichia coli</em>-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology

Published on : Feb 25, 2019

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

See more related videos